Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 14/20 | 0.54 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26630298 | 0.88 | RORC (0.47) | RORCGSK3B | |
| SCHEMBL26630389 | 0.87 | RORC (0.46) | RORCEGFRGSK3B | |
| SCHEMBL26630285 | 0.86 | RORC (0.50) | RORCSCN9ASCN5AEGFRGSK3B | |
| SCHEMBL26630243 | 0.84 | EGFR (0.44) | RORCSCN9ASCN5AEGFR | |
| SCHEMBL26630296 | 0.81 | EGFR (0.45) | RORCEGFRGSK3B | |
| SCHEMBL26630303 | 0.81 | EGFR (0.45) | RORCEGFRGSK3B | |
| SCHEMBL25680363 | 0.74 | NPC1 (0.48) | EGFR | |
| SCHEMBL26630202 | 0.73 | GSK3B (0.46) | EGFRGSK3B | |
| SCHEMBL20647875 | 0.71 | RORC (0.70) | RORC | |
| SCHEMBL17060402 | 0.71 | DRD2 (0.48) | RORCSCN9ASCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282735-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | DONG-A ST CO., LTD. (KR) | 2025-09-11 | — | — | US | disclosed |
| EP-4514780-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | Dong-A ST Co., Ltd. (KR) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023209651-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | DONG-A ST CO., LTD. (KR) | 2023-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282735-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | TEAD1, TEAD2, TEAD3 | RORC 239/4885SCN9A 1124/4885SCN5A 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.